Jan Wenzel

Jan Wenzel

Jan Wenzel

Principal Scientist II

Sanofi

Jan Wenzel studied chemistry in Frankfurt am Main, combining his interests in both math and chemistry by conducting computational research projects dealing with DNA (6-4) photolesions between pyrimidine bases and organic electronics and photovoltaics.

Jan received his Ph.D. from the university of Heidelberg, where he conducted fundamental research for applications in electronics property optimization and simulation of X-ray absorption spectroscopy. During the project, Jan became also co-author of the Q-Chem simulation software package.

Afterwards, Jan started as PostDoc at Sanofi in Frankfurt. The project’s focus was on deep learning in the field of safety big data analytics, to advance the capabilities to analyze, predict and optimize safety parameters of novel drug candidates. Currently, Jan is Scientist for computational and systems toxicology at Sanofi.

Speaked About
December 2, 2026
Explore 2026 EMA trends, AI risk mapping, ppb-level LC-MS/MS, and advanced mitigation for nitrosamines and genotoxic impurity compliance.
Upcoming

DAY 2: December 3rd, 2026

SESSION: Sessinon 

◆  

◆  

Genotoxic Impurities Summit Nitrosamines Beyond
December 2, 2021
Review comprehensive drug impurity profiling strategies in line with regulatory guidelines on new nitrosamine regulations. [Recording: 14 video sessions].
Expired

DAY 1: December 2nd, 2021

SESSION: A Quantum Chemical Approach to Estimate the Mutagenic Potential of Nitrosamines After Metabolic Activation

◆  Computational quantum chemistry approach to assess the reactivity of Nitrosamines.

◆  Introduction of metabolic activation in the calculation of reactivity.

◆  Case studies on different nitrosamines.

Speaker Details
Speaker Details